Tecovirimat failed to reduce clade II mpox lesions, pain or viral clearance among participants in a study of the antiviral ...

Laparoscopic liver resection in posterosuperior segments was linked to a shorter functional recovery time and postoperative ...

When American golfer Gary Woodland won the US Open tournament in 2019, he was on top of the world. Just four years later, he ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control among adults in an ...

A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.

National MS Education and Awareness Month is celebrated each year in the US in March, after having been launched in 2003 by ...

Endometriosis impacts physical, mental, and sexual health. This Endometriosis Awareness Month, let's bring to light what is ...

NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.

Cladribine is part of a wider trend in the NHS toward embracing time-saving innovations. Similar treatments, such as the ...

In a major advancement for ovarian cancer research, a team of scientists from the University of Pittsburgh has identified ...